AGGRENOX is a prescription medication used to lower the risk of stroke in people who have had a "mini-stroke" (transient ischemic attack or TIA) or stroke due to a blood clot.

Why AGGRENOX

Knowing you have an increased risk of a subsequent stroke can be scary. But, by working with your doctor to develop an appropriate treatment plan, you can help reduce your risk. For some, this treatment plan may include AGGRENOX.

AGGRENOX is a prescription medicine that's FDA approved to lower the risk of stroke in people who have had either a TIA (transient ischemic attack or "mini-stroke") or stroke due to a blood clot.

AGGRENOX works by making platelets in the blood less sticky. That means they're less likely to clump together and form blood clots that can block blood flow to the brain—the cause of 87% of strokes.

AGGRENOX is proven to be effective

By combining 2 antiplatelet agents—aspirin and extended-release dipyridamole—AGGRENOX works better than either medicine alone to reduce the risk of a subsequent stroke.

In a clinical study, AGGRENOX helped reduce the risk of stroke in patients who had a TIA or stroke due to a blood clot:

  • Over 90% of patients on AGGRENOX remained stroke-free for 2 years (1493 patients out of a total of 1650).
  • Patients taking AGGRENOX twice daily were 22% less likely to have a stroke than patients taking low-dose aspirin (25 mg twice daily) alone.
  • AGGRENOX was twice as effective as low-dose aspirin (25 mg twice daily) at reducing the risk of a subsequent stroke when tested against a sugar pill.
Dr Pappas Video Play Button

Dr Pappas talks about your increased risk of a subsequent stroke—and what you can do about it.

Dr Pappas talks about the increased risk of a subsequent stroke—and how AGGRENOX can help reduce that risk.

Next:  AGGRENOX Reduces Stroke Risk

Learn about AGGRENOX

Find out how many patients in a clinical study remained stroke-free over 2 years.

learn more

Stroke and TIA Stories

Find out how others are reducing
their risk of a
subsequent
stroke.

view videos

Save on AGGRENOX

You may be eligible for $0 co-pays with the AGGRENOX Co-Pay Card.

Sign up for your co-pay card now

The Taking Smart Steps™ program

Get free tips, tools, and information to help you stay on track with your treatment.

Enroll Now

Be prepared
for your next
doctor's visit

Create a personalized doctor discussion guide to capture your questions
and concerns.

Create your guide now

Insights for caregivers

Caring for someone after a stroke can be difficult.

Get info and advice that may help

Savings and support

Find out about savings on AGGRENOX and FREE support programs.

learn more

Insight for caregivers

Get information tailored to those who are caring for someone who has experienced a stroke or TIA.

learn more

Helpful resources

Learn more about stroke and what you can do to reduce your risk with these resources.

learn more

IMPORTANT SAFETY INFORMATION

Aggrenox® (aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is a prescription medicine used to lower the risk of stroke in people who have had a "mini-stroke" (transient ischemic attack or TIA) or stroke due to a blood clot.

AGGRENOX should be avoided in patients who are allergic to any ingredient in AGGRENOX, or allergic to non-steroidal anti-inflammatory drugs (NSAIDs), or who have the combination of asthma, runny nose, and nasal polyps. AGGRENOX should not be given to a child or teenager.

AGGRENOX increases the risk of bleeding, including bleeding into the brain, stomach or intestines. Any bleeding you have may take longer to stop when you are taking AGGRENOX.

AGGRENOX should be avoided by patients with a history of stomach ulcers or those who drink three or more alcoholic drinks a day, as these can increase the risk of bleeding. Patients should tell their doctor about all medicines they are taking, especially blood thinners, heparin, warfarin, NSAIDs, heart medicines, or medicines for high blood pressure, including diuretics ("water pills").

AGGRENOX should be avoided during pregnancy, especially in the third trimester. AGGRENOX should be avoided in patients with severe liver or kidney problems. The most common side effects of AGGRENOX are headache, upset stomach, and diarrhea.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for full Prescribing Information including Patient Information.

IMPORTANT SAFETY INFORMATION

EXPAND SAFETY INFORMATION

IMPORTANT SAFETY INFORMATION

Aggrenox® (aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is a prescription medicine used to lower the risk of stroke in people who have had a "mini-stroke" (transient ischemic attack or TIA) or stroke due to a blood clot.

AGGRENOX should be avoided in patients who are allergic to any ingredient in AGGRENOX, or allergic to non-steroidal anti-inflammatory drugs (NSAIDs), or who have the combination of asthma, runny nose, and nasal polyps. AGGRENOX should not be given to a child or teenager.

AGGRENOX increases the risk of bleeding, including bleeding into the brain, stomach or intestines. Any bleeding you have may take longer to stop when you are taking AGGRENOX.

AGGRENOX should be avoided by patients with a history of stomach ulcers or those who drink three or more alcoholic drinks a day, as these can increase the risk of bleeding. Patients should tell their doctor about all medicines they are taking, especially blood thinners, heparin, warfarin, NSAIDs, heart medicines, or medicines for high blood pressure, including diuretics ("water pills").

AGGRENOX should be avoided during pregnancy, especially in the third trimester. AGGRENOX should be avoided in patients with severe liver or kidney problems. The most common side effects of AGGRENOX are headache, upset stomach, and diarrhea.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for full Prescribing Information including Patient Information.